ACAD
31.22
-1.78
-5.39%
AEMD
5.1
-0.06
-1.1550%
APRI
0.475
-0.02
-4.0783%
ARNA
1.695
-0.015
-0.877%
ATEC
0.225
0.00
0.00%
CNAT
2.69
-0.03
-1.10%
CRXM
0.19
0.00
0.00%
CYTX
0.277
-0.023
-7.636%
DXCM
62.92
-2.18
-3.35%
GNMK
5.72
-0.12
-2.05%
HALO
10.377
-0.474
-4.3641%
ILMN
134.21
-1.71
-1.26%
INNV
0.091
+0.005
+5.814%
INO
10.62
-0.26
-2.39%
ISCO
3.72
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
121.95
-1.07
-0.87%
LPTN
0.25
+0.035
+16.0465%
MBVX
0.635
-0.025
-3.788%
MEIP
1.45
+0.01
+0.69%
MNOV
6.86
-0.14
-2.00%
MRTX
21.05
-0.5
-2.32%
MSTX
0.31
+0.02
+6.8252%
NBIX
46
-0.71
-1.52%
NUVA
52.27
-0.34
-0.65%
ONCS
1.8
-0.08
-4.26%
ONVO
2.76
-0.07
-2.47%
OREX
0.468
+0.001
+0.2355%
OTIC
14.115
+0.155
+1.110%
QDEL
16.97
-0.21
-1.22%
RCPT
231.96
0.00
0.00%
RGLS
5.605
-0.325
-5.481%
RMD
55.825
-0.305
-0.543%
SPHS
1.35
+0.01
+0.75%
SRNE
6.96
-0.02
-0.29%
TROV
3.85
-0.14
-3.51%
VICL
0.376
-0.004
-1.0784%
VOLC
18
0.00
0.00%
ZGNX
10.5
+0.17
+1.65%
ACAD
31.22
-1.78
-5.39%
AEMD
5.1
-0.06
-1.1550%
APRI
0.475
-0.02
-4.0783%
ARNA
1.695
-0.015
-0.877%
ATEC
0.225
0.00
0.00%
CNAT
2.69
-0.03
-1.10%
CRXM
0.19
0.00
0.00%
CYTX
0.277
-0.023
-7.636%
DXCM
62.92
-2.18
-3.35%
GNMK
5.72
-0.12
-2.05%
HALO
10.377
-0.474
-4.3641%
ILMN
134.21
-1.71
-1.26%
INNV
0.091
+0.005
+5.814%
INO
10.62
-0.26
-2.39%
ISCO
3.72
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
121.95
-1.07
-0.87%
LPTN
0.25
+0.035
+16.0465%
MBVX
0.635
-0.025
-3.788%
MEIP
1.45
+0.01
+0.69%
MNOV
6.86
-0.14
-2.00%
MRTX
21.05
-0.5
-2.32%
MSTX
0.31
+0.02
+6.8252%
NBIX
46
-0.71
-1.52%
NUVA
52.27
-0.34
-0.65%
ONCS
1.8
-0.08
-4.26%
ONVO
2.76
-0.07
-2.47%
OREX
0.468
+0.001
+0.2355%
OTIC
14.115
+0.155
+1.110%
QDEL
16.97
-0.21
-1.22%
RCPT
231.96
0.00
0.00%
RGLS
5.605
-0.325
-5.481%
RMD
55.825
-0.305
-0.543%
SPHS
1.35
+0.01
+0.75%
SRNE
6.96
-0.02
-0.29%
TROV
3.85
-0.14
-3.51%
VICL
0.376
-0.004
-1.0784%
VOLC
18
0.00
0.00%
ZGNX
10.5
+0.17
+1.65%
Home » Archive by Category

NYSE:PFE

Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs

October 5, 2011 – 5:31 am

SAN DIEGO, CA–(Marketwire – Oct 5, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that Lpath has been issued two fur…